Glutaric aciduria type 1 diagnosis was made based on the presence of C5DC in the blood and the C5DC/capryloylcarnitine (C8) ratio detected by MS/MS. In addition, urine GA levels detected by GC–MS as previously reported (E et al., 2017), together with the clinical features and conventional laboratory tests were used for diagnostic purposes. 88 patients’ diagnoses were confirmed by GCDH gene analysis. Patients diagnosed from the NBS program could be asymptomatic.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.